CDXS vs MAS · rev $30.2M vs P/E 18, rev $7.56B
Codexis Inc (CDXS) versus Masco Corporation (MAS) — a side-by-side from cached financials, not a winner call.
Codexis Inc (CDXS) is a biotechnology company listed on US.
Masco Corporation (MAS) is a building products & equipment company listed on US.
Latest reported CDXS revenue for 2026-06-30 was $30.2M. Net income was -$20.7M. Revenue was up 97.8% from 2026-03-31 to 2026-06-30. CDXS currently screens at market cap $257.6M.
Latest reported MAS revenue for 2025-12-31 was $7.56B. Net income was $810.0M. Revenue was down 3.4% from 2024-12-31 to 2025-12-31. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
CDXS currently screens at market cap $257.6M. MAS currently screens at market cap $14.00B and trailing P/E 18.1.
Not investment advice. Open the CDXS and MAS stock pages for the full models.
Not investment advice.